GE HealthCare reported its fourth quarter and full year 2024 financial results, surpassing profit estimates with a diluted earnings per share (EPS) of $1.57, up from $0.88 in the previous year. The adjusted EPS was $1.45, compared to $1.18 a year prior. Revenues reached $5.3 billion, reflecting a 2% increase year-over-year, driven primarily by growth in Advanced Visualization services. The company also provided a positive full-year outlook, contributing to a 1.5% rise in its stock price following the announcement.